These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37782053)

  • 21. AAV6-Mediated IL-10 Expression in the Lung Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Kurosaki F; Uchibori R; Sehara Y; Saga Y; Urabe M; Mizukami H; Hagiwara K; Kume A
    Hum Gene Ther; 2018 Nov; 29(11):1242-1251. PubMed ID: 29598007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-type lectin Mincle initiates IL-17-mediated inflammation in acute exacerbations of idiopathic pulmonary fibrosis.
    Tao C; Xian H; Nian-Yu Z; Jia-Cui S; Dong W; Hui-Ping L
    Biomed Pharmacother; 2023 Mar; 159():114253. PubMed ID: 36680813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NOX4 regulates macrophage apoptosis resistance to induce fibrotic progression.
    Larson-Casey JL; Gu L; Kang J; Dhyani A; Carter AB
    J Biol Chem; 2021 Jul; 297(1):100810. PubMed ID: 34023385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective depletion of CD11b-positive monocytes/macrophages potently suppresses bleomycin-induced pulmonary fibrosis.
    Wan X; Xiao Y; Tian X; Lu Y; Chu H
    Int Immunopharmacol; 2023 Jan; 114():109570. PubMed ID: 36700767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small GTPase RAB6 deficiency promotes alveolar progenitor cell renewal and attenuates PM2.5-induced lung injury and fibrosis.
    Yang L; Liu G; Li X; Xia Z; Wang Y; Lin W; Zhang W; Zhang W; Li X
    Cell Death Dis; 2020 Oct; 11(10):827. PubMed ID: 33012781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
    Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
    Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis.
    Nagai T; Tanaka M; Hasui K; Shirahama H; Kitajima S; Yonezawa S; Xu B; Matsuyama T
    Clin Exp Immunol; 2010 Aug; 161(2):348-56. PubMed ID: 20550546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage.
    Garcia O; Carraro G; Turcatel G; Hall M; Sedrakyan S; Roche T; Buckley S; Driscoll B; Perin L; Warburton D
    PLoS One; 2013; 8(8):e71679. PubMed ID: 23967234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7H3-dependent myeloid-derived suppressor cell recruitment and activation in pulmonary fibrosis.
    Liu T; Gonzalez De Los Santos F; Rinke AE; Fang C; Flaherty KR; Phan SH
    Front Immunol; 2022; 13():901349. PubMed ID: 36045668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.
    Mackinnon AC; Gibbons MA; Farnworth SL; Leffler H; Nilsson UJ; Delaine T; Simpson AJ; Forbes SJ; Hirani N; Gauldie J; Sethi T
    Am J Respir Crit Care Med; 2012 Mar; 185(5):537-46. PubMed ID: 22095546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19.
    Li HH; Liu CC; Hsu TW; Lin JH; Hsu JW; Li AF; Yeh YC; Hung SC; Hsu HS
    Part Fibre Toxicol; 2021 Mar; 18(1):11. PubMed ID: 33706759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical role for iron accumulation in the pathogenesis of fibrotic lung disease.
    Ali MK; Kim RY; Brown AC; Donovan C; Vanka KS; Mayall JR; Liu G; Pillar AL; Jones-Freeman B; Xenaki D; Borghuis T; Karim R; Pinkerton JW; Aryal R; Heidari M; Martin KL; Burgess JK; Oliver BG; Trinder D; Johnstone DM; Milward EA; Hansbro PM; Horvat JC
    J Pathol; 2020 May; 251(1):49-62. PubMed ID: 32083318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myeloid Fbxw7 Prevents Pulmonary Fibrosis by Suppressing TGF-β Production.
    He J; Du Y; Li G; Xiao P; Sun X; Song W; Lai L; Xia M; Zhang J; Wang Q
    Front Immunol; 2021; 12():760138. PubMed ID: 35069531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension.
    Karmouty-Quintana H; Philip K; Acero LF; Chen NY; Weng T; Molina JG; Luo F; Davies J; Le NB; Bunge I; Volcik KA; Le TT; Johnston RA; Xia Y; Eltzschig HK; Blackburn MR
    FASEB J; 2015 Jan; 29(1):50-60. PubMed ID: 25318478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
    Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 37. Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls [corrected].
    Krempaska K; Barnowski S; Gavini J; Hobi N; Ebener S; Simillion C; Stokes A; Schliep R; Knudsen L; Geiser TK; Funke-Chambour M
    Respir Res; 2020 Jan; 21(1):25. PubMed ID: 31941499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis.
    Nakahara Y; Hashimoto N; Sakamoto K; Enomoto A; Adams TS; Yokoi T; Omote N; Poli S; Ando A; Wakahara K; Suzuki A; Inoue M; Hara A; Mizutani Y; Imaizumi K; Kawabe T; Rosas IO; Takahashi M; Kaminski N; Hasegawa Y
    Eur Respir J; 2021 Dec; 58(6):. PubMed ID: 34049947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IRAK-M Regulates Monocyte Trafficking to the Lungs in Response to Bleomycin Challenge.
    Reader BF; Sethuraman S; Hay BR; Thomas Becket RV; Karpurapu M; Chung S; Lee YG; Christman JW; Ballinger MN
    J Immunol; 2020 May; 204(10):2661-2670. PubMed ID: 32253243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.